Doxifluridine Market

It is antitumor drug, is the precursor of fluorouracil (5 FU), within the tumor tissue by the effect of pyrimidine nucleoside phosphorylase, converted to free fluorouracil, thereby inhibiting tumor cell biosynthesis of DNA, RNA, shows that its anti-tumor effect. Due to the activity of the enzyme in the tumor tissue compared with normal tissue is high, so the product in tumor converted into 5 - FU speed for selective tumor. For the treatment of breast cancer, gastric cancer, colorectal cancer,

Doxifluridine Market contains market size and forecasts of Doxifluridine in Global, including the following market information:

Global Doxifluridine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Doxifluridine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Doxifluridine include Ipsen, Roche, Nippon Kayaku, DSM Nutritional Products AG, Jiangsu Zhengda Qingjiang Pharmaceutical, Tonghua Maoxiang Pharmaceutical, Shandong New Era Pharmaceutical, Anhui Huarun Jinchan Pharmaceutical and Jiangsu Shengdi Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Doxifluridine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Doxifluridine Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Doxifluridine Market Segment Percentages, by Type, 2021 (%)

Injection

Tablets

Capsule

Global Doxifluridine Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Doxifluridine Market Segment Percentages, by Application, 2021 (%)

Antimetabolic Use

Hormone

Cancer Drugs

Antibiotic Medicine

Global Doxifluridine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Doxifluridine Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Doxifluridine revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Doxifluridine revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Ipsen

Roche

Nippon Kayaku

DSM Nutritional Products AG

Jiangsu Zhengda Qingjiang Pharmaceutical

Tonghua Maoxiang Pharmaceutical

Shandong New Era Pharmaceutical

Anhui Huarun Jinchan Pharmaceutical

Jiangsu Shengdi Pharmaceutical

Shandong Xinqi Pharmaceutical

Shaanxi Dongtai Pharmaceutical

Jilin Aodong Medicine Yanji

Zhejiang Guobang Pharmaceutical

Zhejiang Haizheng Pharmaceutical

Yangtze Pharmaceutical Group

Ningbo Tianheng Pharmaceutical

Shanghai Pacific Pharmaceutical

Shanghai Zhaohui Pharmaceutical

Zibo Wanjie Pharmaceutical

Jiangsu Hengrui Pharmaceutical

Hainan General Tongmeng Pharmaceutical